Literature DB >> 17286533

Unraveling hypertension: epigenomics comes of age.

Myriam Fornage.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17286533     DOI： 10.2217/14622416.8.2.125

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  5 in total

Review 1.  Pharmacogenetics of antihypertensive treatment: detailing disciplinary dissonance.

Authors:  Donna K Arnett; Steven A Claas
Journal:  Pharmacogenomics       Date:  2009-08       Impact factor: 2.533

2.  Genome-wide identification of long noncoding RNAs in rat models of cardiovascular and renal disease.

Authors:  Kathirvel Gopalakrishnan; Sivarajan Kumarasamy; Blair Mell; Bina Joe
Journal:  Hypertension       Date:  2014-11-10       Impact factor: 10.190

3.  Essential hypertension: perspectives and future directions.

Authors:  Songcang Chen
Journal:  J Hypertens       Date:  2012-01       Impact factor: 4.844

4.  The ghost in our genes: legal and ethical implications of epigenetics.

Authors:  Mark A Rothstein; Yu Cai; Gary E Marchant
Journal:  Health Matrix Clevel       Date:  2009

5.  Prolonged exposure to particulate pollution, genes associated with glutathione pathways, and DNA methylation in a cohort of older men.

Authors:  Jaime Madrigano; Andrea Baccarelli; Murray A Mittleman; Robert O Wright; David Sparrow; Pantel S Vokonas; Letizia Tarantini; Joel Schwartz
Journal:  Environ Health Perspect       Date:  2011-03-08       Impact factor: 9.031
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.